PMEL and neoplasm: In the context of immunotherapy, liposomes encapsulating mRNA encoding tumor-associated antigens (such as TRP-2 or gp100), combined with lipid-based adjuvants like MPLA, promoted up to a 6-fold increase in CD8+ T cell proliferation and significantly elevated serum IFN-γ levels compared to non-encapsulated controls [172].